Searched for
BIOCON STOCK NEWS
Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block dealActive Pine is likely to sell up to 1.66 crore Biocon shares, worth Rs 638 crore, through a block deal at Rs 385 per share. The development...- Cochin Shipyard and Patanjali Foods among top 5 midcap stocks that saw highest mutual fund buying in JulyMutual funds increased buying in five midcap stocks during July, led by Rail Vikas, Cochin Shipyard, Patanjali Foods, Biocon and Tata Elxsi...
- Stocks in news: Tata Elxsi, HCL Tech, ICICI Pru AMC, Biocon, SpiceJetIndian markets closed nearly unchanged after a volatile trading session on Monday. Tata Elxsi and L&T Tech shares are in focus as they anno...
- Biocon shares fall 3% after board approves fundraise of up to Rs 4,500 croreBiocon shares: The board approved a hike in the company’s authorised share capital from Rs 625 crore to Rs 700 crore, along with a correspo...
- Biocon shares in focus after subsidiary launches biosimilar alternative to Stelara in the USBiocon Biologics has launched YESINTEK, a biosimilar to Stelara, in the United States for treating chronic autoimmune conditions, offering ...
- HSBC sees Biocon share price rallying up to Rs 430; stock surges 5%Biocon Ltd shares rose 4.7% after HSBC upgraded its rating to "buy" and raised the target price to Rs 430. The upgrade reflects a turnaroun...
- Buy Biocon, target price Rs 390: Axis SecuritiesBiocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 40868.42 Crore) operating in Pharmaceuticals ...
- Buy Biocon, target price Rs 370: Anand RathiBiocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 37404.69 Crore) operating in Pharmaceuticals ...
- Stock Radar: Fresh multi-year high in April! Why Biocon is a long-term pick for investorsBiocon stock broke out from a Symmetrical Triangle pattern last week on the monthly charts, which has opened room for it to head higher and...
- Buy Biocon, target price Rs 340: Anand RathiBiocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals, Other Operating Revenue, Waste and Sale of services for the year end...
- Biocon shares jump 8% post Q4 results. Is the Street happy?Biocon's shares surged by 8% on Tuesday due to strong Q4 earnings growth. Net profit grew by 31% to INR 313 crore with 57% YoY growth in co...
- Biocon drops 4% as USFDA issues form 483 for 3 sitesAs per the US Food and Drug Administration (USFDA), Form 483 is issued to a firm's management at the conclusion of an inspection when an in...
- Hold Biocon, target price Rs 380: ICICI DirectBiocon, incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 44314.15 crore) operating in Pharmaceuticals secto...
- Viatris deal pinches Biocon, but may prove a good betThe $3.3-billion acquisition - that includes $2.3 billion cash and a 12.9% equity stake in BBL - stands at over half of the market cap of B...
- Biocon shares drop after French regulator finds lapses at its plantANSM has raised deficiencies concerning two biosimilar products intended in the treatment of cancer and one intended for diabetes.
- D-Street may be ignoring Biocon’s growth risksThe stock price has priced in all the near-term positives arising from the business — leaving little room for any risks.
- Return ratios for Biocon to remain tepid; prefer Sun Pharma among pharma names: Mayuresh JoshiInvestors must adopt stock-specific approach as valuations have turned expensive on pharma counters, says Joshi in an interview to ET Now.
- Biocon to stay buoyant going forward: Mehraboon IraniBullish on Biocon, recommend it even now before a dip: Mehraboon Irani.
- Biocon enters in partnership with Bristol-Myers Squibb; stock upThe stock has been in an uptrend this week and has moved nearly 5% higher, while for the month of November Biocon surged over 16%.
- Biocon can move up another 6% to 8%: Ambareesh BaligaThose who have been holding on to this stock for a long time, it has been a bit of a underperformer if you see in the last 1-1.5 years. So ...
Load More
